Cargando…

Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study

PURPOSE: CHOICE (CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE therapy) assessed patterns of exenatide bid and initial insulin therapy usage in clinical practice in six European countries and evaluated outcomes during the study. METHODS: CHOICE was a 24-mon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiiskinen, Urpo, Matthaei, Stephan, Reaney, Matthew, Mathieu, Chantal, Östenson, Claes-Göran, Krarup, Thure, Theodorakis, Michael, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Guerci, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713896/ https://www.ncbi.nlm.nih.gov/pubmed/23874113 http://dx.doi.org/10.2147/CEOR.S44060

Ejemplares similares

Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE
por: Mathieu, Chantal, et al.
Publicado: (2013)

Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study
por: Reaney, Matthew, et al.
Publicado: (2013)

Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries
por: Östenson, Claes-Göran, et al.
Publicado: (2013)

Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study
por: Matthaei, Stephan, et al.
Publicado: (2012)

Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study
por: Simó, Rafael, et al.
Publicado: (2015)

Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials
por: Vetter, Marion L., et al.
Publicado: (2019)

Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes
por: Ratner, Robert, et al.
Publicado: (2011)

Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study
por: Pawaskar, Manjiri, et al.
Publicado: (2013)

Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies
por: McDonell, Amanda L, et al.
Publicado: (2015)

PyBIDS: Python tools for BIDS datasets
por: Yarkoni, Tal, et al.
Publicado: (2019)

Bidding adieu
por: Verma, Shyam
Publicado: (2015)

Bidding Adieu…
por: Desai, Chetna
Publicado: (2017)

Bid Adieu……
por: Agarwal, Sanjay Kumar
Publicado: (2022)

A dynamic novel approach for bid/no-bid decision-making
por: Shi, Huawang, et al.
Publicado: (2016)

Curation of BIDS (CuBIDS): A workflow and software package for streamlining reproducible curation of large BIDS datasets
por: Covitz, Sydney, et al.
Publicado: (2022)

MNE-BIDS: Organizing electrophysiological data into the BIDS format and facilitating their analysis
por: Appelhoff, Stefan, et al.
Publicado: (2019)

Creating Winning Bids
por: Sawczuk, Basil
Publicado: (2019)

Editor Bids Adieu
por: Mysore, Venkataram
Publicado: (2011)

Bidding adieu IJP
por: Prakash, Shiv
Publicado: (2009)

Bidding for Pauper Practice
por: Wright, John
Publicado: (1878)

Bidding for Pauper Practice
Publicado: (1878)

Bid for power : English for commerce and industry /
por: Fitzpatrick, A.
Publicado: (1983)

Population pharmacokinetics of exenatide
por: Cirincione, Brenda, et al.
Publicado: (2016)

IT IS TIME NOW TO BID ADIEU!
por: Dhar, Sandipan
Publicado: (2011)

AARNet in bid for speed record
por: MacKenzie, Kate
Publicado: (2004)

The Lives We Have Bid to Be
Publicado: (1894)

Medical Fees and Under Bidding
Publicado: (1880)

Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas
por: Davies, Melanie, et al.
Publicado: (2013)

Differential role of FL-BID and t-BID during verotoxin-1-induced apoptosis in Burkitt’s lymphoma cells
por: Debernardi, Justine, et al.
Publicado: (2018)

BidSi6 and BidEL isoforms as a potential marker for predicting colorectal adenomatous polyps
por: Forouzesh, Flora, et al.
Publicado: (2022)

Long-acting preparations of exenatide
por: Cai, Yunpeng, et al.
Publicado: (2013)

Writing business bids & proposals for dummies
por: Cobb, Neil, et al.
Publicado: (2016)

Oracle bids for piece of networking action
por: Lillington, K
Publicado: (2003)

Bid Regulates the Pathogenesis of Neurotropic Reovirus
por: Danthi, Pranav, et al.
Publicado: (2010)

Bidding the CpG island goodbye
por: Greally, John M
Publicado: (2013)

Reevaluation of CMS’ Competitive Bidding Program
por: Schatz, Desmond, et al.
Publicado: (2016)

Powdered gloves: Time to bid adieu
por: Srinivasan, S
Publicado: (2018)

Powdered gloves: Time to bid adieu
por: Baid, R, et al.
Publicado: (2017)

Bidding Adieu to IAP Year 2022
por: Remesh Kumar, R
Publicado: (2022)

Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks
por: Diamant, Michaela, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_65nigfbi14161v0k1c5fujf568